Hyperactive K-RAS signaling is a major menace that drives aggressive cancer cell dissemination, tumor progression and systemic metastasis in human pancreatic cancer. Counteracting K-RAS hyperactivation in attempt…
Hyperactive K-RAS signaling is a major menace that drives aggressive cancer cell dissemination, tumor progression and systemic metastasis in human pancreatic cancer. Counteracting K-RAS hyperactivation in attempt…
Hyperactive K-RAS signaling is a major menace that drives aggressive cancer cell dissemination, tumor progression and systemic metastasis in human pancreatic cancer. Counteracting K-RAS hyperactivation in attempt…
Despite considerable research on K-Ras inhibitors, none had been developed until now. We synthesized nuclease-resistant synthetic miR-143 (miR-143#12), which strongly silenced K-Ras, its effector ... signal molecules…
Ras proteins belong to the GTPase superfamily of proteins; they consist of HRas, NRas and KRas. Ras is involved in various cellular functions cell growth, proliferation, differentiation and activation. Ras ... proteins…
Interaction between the Wnt/beta-catenin and the Ras-ERK pathways, two major transforming pathways, have been posited. However, molecular mechanisms and cooperative roles of these two pathways are poorly ... KRAS…
Ras proteins (KRas, HRas, and NRas) are small GTPases that function as molecular switches at the inner plasma membrane by alternating between GTP-bound active forms (Ras ... bound (Ras-GDP) inactive forms. Oncogenic…
pivotal role as one of the primary enzymes within the Renin-Angiotensin System (RAS), responsible for regulating the homeostasis of different organs. RAS hyperactivity, accompanied by an increase ... Probably using the…
Ras is found mutated in about 20% of human cancers, associated with poor prognosis due to a lack of drugs able to deter uncontrolled signaling through multiple pathways ... cell. There are three isoforms: H-, K-, and…
Objective: Inhibitors of renin angiotensin system (RAS), ACE inhibitors (ACEI) and angiotensin II receptor blockers (ARBs), are frequently used as renal-protective agents in type 2 diabetes (T2D). However, there…
Background: Recurrent aphthous stomatitis (RAS) still the most collective aching oral complain with uncertain etiopathology. Saliva is the promising noninvasive diagnostic media used in a lot of biomedical research…
Mutations in codons 12/13 of K-ras exon 2 are associated with reduced benefit from anti-epidermal growth factor receptor antibody treatment for metastatic colorectal cancer (CRC). Here ... evaluated the frequency of…
Three decades after the identification of Ras as an oncogene, the field remains as dynamic and important as ever. Ras controls a wide variety of biological processes including cell growth ... developmental disorders…
established therapeutic targets and is consequently among the deadliest malignancies with near-universal K-Ras mutations. Here, we report that a K-Ras effector p38γ (MAPK12) is required for pancreatic ... pancreatic…
RAS family of GTPases is frequently mutated in human cancers. The current therapeutic strategies to target mutant RAS driven cancers rely mostly on inhibitors that either block the farnesylation/geranylation ... RAS or…
microarray results with gene synergical analysis, at the priming phase, activation of integrin/Grb2/Ras pathway in hepatocytes apparently contributed to G0/G1 transition. Two other pathways, G-protein/EPAC…
This study comparatively assessed the technical and economic performance of two RAS designs for the culture of African Catfish (Clarias gariepinus). A total of 1000 Catfish fingerlings each were stocked ... circular…
RAS family of GTPases is frequently mutated in human cancers. The current therapeutic strategies to target mutant RAS driven cancers rely mostly on inhibitors that either block the farnesylation/geranylation ... RAS or…
RAS family of GTPases is frequently mutated in human cancers. The current therapeutic strategies to target mutant RAS driven cancers rely mostly on inhibitors that either block the farnesylation/geranylation ... RAS or…
RAS family of GTPases is frequently mutated in human cancers. The current therapeutic strategies to target mutant RAS driven cancers rely mostly on inhibitors that either block the farnesylation/geranylation ... RAS or…
process by which extracellular information is transmitted into the cell to perform biological functions. RAS-MAPK signaling pathway controls several cellular processes such as cell growth, proliferation, and gene…
Ras proteins are small GTPases, which serve as master regulators of a myriad of signaling cascades involved in highly diverse cellula r processes. Activating mutations in Ras are found ... about one-third of cancers…
playing a pivotal role in thyroid cancer onset. BRAF, RET/PTC or N-Ras mutations are referred as markers of malignancy for papillary carcinoma (PTC), the most common thyroid malignancy ... only in 20% of its follicular…
cyclin D and fibroblast growth factor receptor 3 (FGFR3) and mutations in NRas. Oncogenic Ras isoforms can be inhibited by the Ras inhibitor farnesylthiosalicylic acid (FTS, salirasib), which also inhibits…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.